Cabaletta Bio, Inc. (CABA)
0.9361
-0.07
(-7.32%)
USD |
NASDAQ |
Nov 20, 16:00
0.9397
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Price to Book Value : 0.7112 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.7112 |
| November 19, 2026 | 0.7674 |
| November 18, 2026 | 0.8016 |
| November 17, 2026 | 0.775 |
| November 16, 2026 | 0.8434 |
| November 13, 2026 | 0.9725 |
| November 12, 2026 | 1.010 |
| November 11, 2026 | 1.102 |
| November 10, 2026 | 1.102 |
| November 09, 2026 | 1.140 |
| November 06, 2026 | 0.9877 |
| November 05, 2026 | 0.9725 |
| November 04, 2026 | 1.079 |
| November 03, 2026 | 1.079 |
| November 02, 2026 | 1.086 |
| October 30, 2026 | 1.147 |
| October 29, 2026 | 1.204 |
| October 28, 2026 | 1.155 |
| October 27, 2026 | 1.106 |
| October 26, 2026 | 1.026 |
| October 23, 2026 | 1.117 |
| October 22, 2026 | 1.155 |
| October 21, 2026 | 1.170 |
| October 20, 2026 | 1.223 |
| October 19, 2026 | 1.124 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.071 |
| October 15, 2026 | 1.178 |
| October 14, 2026 | 1.231 |
| October 13, 2026 | 1.284 |
| October 12, 2026 | 1.36 |
| October 09, 2026 | 1.466 |
| October 08, 2026 | 1.482 |
| October 07, 2026 | 1.497 |
| October 06, 2026 | 1.535 |
| October 05, 2026 | 1.580 |
| October 02, 2026 | 1.520 |
| October 01, 2026 | 1.436 |
| September 30, 2026 | 1.459 |
| September 29, 2026 | 1.577 |
| September 28, 2026 | 1.593 |
| September 25, 2026 | 1.649 |
| September 24, 2026 | 1.716 |
| September 23, 2026 | 1.768 |
| September 22, 2026 | 1.991 |
| September 21, 2026 | 1.959 |
| September 18, 2026 | 2.031 |
| September 17, 2026 | 2.055 |
| September 16, 2026 | 1.983 |
| September 15, 2026 | 2.067 |
| September 14, 2026 | 2.318 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 16.42 |
| Anika Therapeutics, Inc. | 1.288 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.268 |
Price to Book Value Related Metrics
| Price | 0.9361 |
| Earnings Yield | -152.5% |
| Market Cap | 201.94M |